Global Platinum based Cancer Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112290802 | Category: Pharma & Healthcare | Pages: 102 | Format: PDF | Published Date: November 17,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Platinum based Cancer Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Platinum based Cancer Drug market size is estimated to be worth US$ 1586.5 million in 2021 and is forecast to a readjusted size of USD 1896.7 million by 2028 with a CAGR of 2.6% during review period. Colorectal Cancer accounting for % of the Platinum based Cancer Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cisplatin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Platinum based Cancer Drug include Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, and Qilu Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Platinum based Cancer Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Cisplatin
    Oxaliplatin
    Carboplatin
    Others
Market segment by Application can be divided into
    Colorectal Cancer
    Ovarian Cancer
    Lung Cancer
    Others
The key market players for global Platinum based Cancer Drug market are listed below:
    Sanofi
    Hengrui Medicine
    ASK Pharma
    Yi Bai Pharmaceutical
    Qilu Pharmaceutical
    Teva
    Pfizer
    Dr Reddy's Laboratories
    Mylan
    Sun Pharma
    Novartis
    Debiopharm
    Accord Healthcare
    SK Chemicals
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Platinum based Cancer Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Platinum based Cancer Drug, with price, sales, revenue and global market share of Platinum based Cancer Drug from 2019 to 2022.
Chapter 3, the Platinum based Cancer Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Platinum based Cancer Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Platinum based Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Platinum based Cancer Drug.
Chapter 13, 14, and 15, to describe Platinum based Cancer Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Platinum based Cancer Drug Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Platinum based Cancer Drug Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Cisplatin
        1.2.3 Oxaliplatin
        1.2.4 Carboplatin
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Platinum based Cancer Drug Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Colorectal Cancer
        1.3.3 Ovarian Cancer
        1.3.4 Lung Cancer
        1.3.5 Others
    1.4 Global Platinum based Cancer Drug Market Size & Forecast
        1.4.1 Global Platinum based Cancer Drug Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Platinum based Cancer Drug Sales in Volume (2017-2028)
        1.4.3 Global Platinum based Cancer Drug Price (2017-2028) 
    1.5 Global Platinum based Cancer Drug Production Capacity Analysis
        1.5.1 Global Platinum based Cancer Drug Total Production Capacity (2017-2028)
        1.5.2 Global Platinum based Cancer Drug Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Platinum based Cancer Drug Market Drivers
        1.6.2 Platinum based Cancer Drug Market Restraints
        1.6.3 Platinum based Cancer Drug Trends Analysis
2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Platinum based Cancer Drug Product and Services
        2.1.4 Sanofi Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Hengrui Medicine
        2.2.1 Hengrui Medicine Details
        2.2.2 Hengrui Medicine Major Business
        2.2.3 Hengrui Medicine Platinum based Cancer Drug Product and Services
        2.2.4 Hengrui Medicine Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 ASK Pharma
        2.3.1 ASK Pharma Details
        2.3.2 ASK Pharma Major Business
        2.3.3 ASK Pharma Platinum based Cancer Drug Product and Services
        2.3.4 ASK Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Yi Bai Pharmaceutical
        2.4.1 Yi Bai Pharmaceutical Details
        2.4.2 Yi Bai Pharmaceutical Major Business
        2.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Product and Services
        2.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Qilu Pharmaceutical
        2.5.1 Qilu Pharmaceutical Details
        2.5.2 Qilu Pharmaceutical Major Business
        2.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Product and Services
        2.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Platinum based Cancer Drug Product and Services
        2.6.4 Teva Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Platinum based Cancer Drug Product and Services
        2.7.4 Pfizer Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Dr Reddy's Laboratories
        2.8.1 Dr Reddy's Laboratories Details
        2.8.2 Dr Reddy's Laboratories Major Business
        2.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Product and Services
        2.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Mylan
        2.9.1 Mylan Details
        2.9.2 Mylan Major Business
        2.9.3 Mylan Platinum based Cancer Drug Product and Services
        2.9.4 Mylan Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Sun Pharma
        2.10.1 Sun Pharma Details
        2.10.2 Sun Pharma Major Business
        2.10.3 Sun Pharma Platinum based Cancer Drug Product and Services
        2.10.4 Sun Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Novartis
        2.11.1 Novartis Details
        2.11.2 Novartis Major Business
        2.11.3 Novartis Platinum based Cancer Drug Product and Services
        2.11.4 Novartis Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Debiopharm
        2.12.1 Debiopharm Details
        2.12.2 Debiopharm Major Business
        2.12.3 Debiopharm Platinum based Cancer Drug Product and Services
        2.12.4 Debiopharm Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Accord Healthcare
        2.13.1 Accord Healthcare Details
        2.13.2 Accord Healthcare Major Business
        2.13.3 Accord Healthcare Platinum based Cancer Drug Product and Services
        2.13.4 Accord Healthcare Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 SK Chemicals
        2.14.1 SK Chemicals Details
        2.14.2 SK Chemicals Major Business
        2.14.3 SK Chemicals Platinum based Cancer Drug Product and Services
        2.14.4 SK Chemicals Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Platinum based Cancer Drug Breakdown Data by Manufacturer
    3.1 Global Platinum based Cancer Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Platinum based Cancer Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Platinum based Cancer Drug
    3.4 Market Concentration Rate
        3.4.1 Top 3 Platinum based Cancer Drug Manufacturer Market Share in 2021
        3.4.2 Top 6 Platinum based Cancer Drug Manufacturer Market Share in 2021
    3.5 Global Platinum based Cancer Drug Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Platinum based Cancer Drug Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Platinum based Cancer Drug Market Size by Region
        4.1.1 Global Platinum based Cancer Drug Sales in Volume by Region (2017-2028)
        4.1.2 Global Platinum based Cancer Drug Revenue by Region (2017-2028)
    4.2 North America Platinum based Cancer Drug Revenue (2017-2028)
    4.3 Europe Platinum based Cancer Drug Revenue (2017-2028)
    4.4 Asia-Pacific Platinum based Cancer Drug Revenue (2017-2028)
    4.5 South America Platinum based Cancer Drug Revenue (2017-2028)
    4.6 Middle East and Africa Platinum based Cancer Drug Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Platinum based Cancer Drug Sales in Volume by Type (2017-2028)
    5.2 Global Platinum based Cancer Drug Revenue by Type (2017-2028)
    5.3 Global Platinum based Cancer Drug Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Platinum based Cancer Drug Sales in Volume by Application (2017-2028)
    6.2 Global Platinum based Cancer Drug Revenue by Application (2017-2028)
    6.3 Global Platinum based Cancer Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Platinum based Cancer Drug Sales by Type (2017-2028)
    7.2 North America Platinum based Cancer Drug Sales by Application (2017-2028)
    7.3 North America Platinum based Cancer Drug Market Size by Country
        7.3.1 North America Platinum based Cancer Drug Sales in Volume by Country (2017-2028)
        7.3.2 North America Platinum based Cancer Drug Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Platinum based Cancer Drug Sales by Type (2017-2028)
    8.2 Europe Platinum based Cancer Drug Sales by Application (2017-2028)
    8.3 Europe Platinum based Cancer Drug Market Size by Country
        8.3.1 Europe Platinum based Cancer Drug Sales in Volume by Country (2017-2028)
        8.3.2 Europe Platinum based Cancer Drug Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Platinum based Cancer Drug Sales by Type (2017-2028)
    9.2 Asia-Pacific Platinum based Cancer Drug Sales by Application (2017-2028)
    9.3 Asia-Pacific Platinum based Cancer Drug Market Size by Region
        9.3.1 Asia-Pacific Platinum based Cancer Drug Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Platinum based Cancer Drug Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Platinum based Cancer Drug Sales by Type (2017-2028)
    10.2 South America Platinum based Cancer Drug Sales by Application (2017-2028)
    10.3 South America Platinum based Cancer Drug Market Size by Country
        10.3.1 South America Platinum based Cancer Drug Sales in Volume by Country (2017-2028)
        10.3.2 South America Platinum based Cancer Drug Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Platinum based Cancer Drug Sales by Type (2017-2028)
    11.2 Middle East & Africa Platinum based Cancer Drug Sales by Application (2017-2028)
    11.3 Middle East & Africa Platinum based Cancer Drug Market Size by Country
        11.3.1 Middle East & Africa Platinum based Cancer Drug Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Platinum based Cancer Drug Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Platinum based Cancer Drug and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Platinum based Cancer Drug
    12.3 Platinum based Cancer Drug Production Process
    12.4 Platinum based Cancer Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Platinum based Cancer Drug Typical Distributors
    13.3 Platinum based Cancer Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Platinum based Cancer Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?